@misc{bed142038de74e72b94d962d4f50a83b,
title = "There is no sufficient reason to give “last hope” drugs approval and funding",
author = "Martijn Boot",
year = "2024",
month = may,
day = "7",
language = "English",
series = "CPLB Dilemmas: Dilemma #8, Should “last hope” drugs get priority approval and funding over other drugs even when they otherwise offer a less favorable balance of risks to prospective benefits?",
publisher = "Center for Population-Level Bioethics, Rutgers University",
type = "Other",
}